1. Open Access Description

China Pharmacy is a double-blind peer-reviewed journal. As of June 21, 2022, China Pharmacy has officially become an open-access journal. All content is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC-BY-NC-ND 4.0) license. Under this license, all articles are freely accessible immediately and permanently on the official website (https://journal.china-pharmacy.com/). Users may read, download, copy, print, search, or link to the full text of the articles or use them for other lawful purposes.

2. License Agreement

China Pharmacy shares articles under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC-BY-NC-ND 4.0) license. Authors agree that their articles are published under this license. Users of the journal's articles must adhere to the CC-BY-NC-ND 4.0 license. This license permits users to copy and distribute articles, provided that:

1. Use is for non-commercial purposes only, and the article cannot be modified, edited, or distributed in any altered form.

2. Users must have appropriate attribution, linking to the article via DOI, and provide the license link without implying endorsement by the author or licensor.

3. Distribution of any derivative works, including recomposing, altering the format of the publication, or building upon the original material, is prohibited.

3. Copyright

The copyright of all articles published in China Pharmacy is owned by Chongqing University Cancer Hospital. All open-access articles adhere to the CC-BY-NC-ND 4.0 license.

4. Availability and Reusability of Archived Materials

Before China Pharmacy transitioned to an open-access (OA) journal, physical archive materials were subscription-based, while electronic archive materials were freely accessible (https://jc.china-pharmacy.com/9), with access to articles dating back to 2013. As for the reusability, the journal implements an open-access policy for archived materials.